Delivery Order SPE2DB25D3003-SPE2DB25FPXDK
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $7,793.99 firm fixed-price delivery order for Lo Loestrin Fe 1-10 tablets (28-count supply) on August 19, 2025, with an ultimate completion date of August 20, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $6,208.22 to AmerisourceBergen Drug Corp for Loestrin FE 1-20 tablets on July 30, 2025, with performance completion by July 31, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The pharmaceutical product will be supplied to support federal medical procurement needs, with performance occurring at the contractor's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $11,160.66 to AmerisourceBergen Drug Corp for Lo Loestrin Fe 1-10 tablets (28-count packages) on August 25, 2025, with an ultimate completion date of August 26, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded a $3,400.87 firm fixed-price delivery order to AmerisourceBergen Drug Corp for LOESTRIN FE 1-20 tablets (28-count packaging) on August 21, 2025, with an ultimate completion date of August 22, 2025. This is a non-set-aside, competitively awarded contract executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $14,675.22 to AmerisourceBergen Drug Corp for the supply of Loestrin FE 1-20 tablets in 28-count packages. The contract is firm fixed price with no set-aside designation and carries an ultimate completion date of July 30, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania will serve as the place of performance for this pharmaceutical delivery. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $2,838.58 to AmerisourceBergen Drug Corp for Loestrin 21 1-20 Tablet (21-count packages) on August 19, 2025, with an ultimate completion date of August 20, 2025. This competitive award, which received no set-aside designation, represents a firm fixed-price delivery order to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract is a child award issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,247.15 on July 21, 2025, for the supply of Lo Loestrin FE 1-10 tablets in 28-count packages. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement with an ultimate completion date of July 22, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,599.91 to AmerisourceBergen Drug Corp for Lo Loestrin FE 1-10 Tablet 28s, a hormonal contraceptive pharmaceutical product. This firm fixed-price delivery order, issued on August 19, 2025, with an ultimate completion date of August 20, 2025, was awarded without set-aside restrictions through competitive procurement. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,560.38 to AmerisourceBergen Drug Corp for Lo Loestrin FE 1-10 Tablet 28s, a hormonal contraceptive medication. The contract, awarded on September 2, 2025, with an ultimate completion date of September 3, 2025, utilizes firm fixed pricing with no set-aside designation, indicating competitive award. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $5,733.50 to AmerisourceBergen Drug Corp for Loestrin FE 1.5-30 tablets (28-count units) with a firm fixed price contract type. The award was made on September 3, 2025, with an ultimate completion date of September 4, 2025, and represents a non-set-aside competitive procurement. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's broader...
- SPE2DB25D3003Indefinite Delivery Contract
- SPE2DB25D3003-SPE2DB25FPXDKDelivery Order
The Defense Logistics Agency awarded a $6,576.67 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Loestrin FE 1-20 tablets (28-count packaging) on September 11, 2025, with completion targeted for September 12, 2025. This non-competitive delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order supports the Defense Health Agency's pharmaceutical supply chain requirements through AmerisourceBergen's comprehensive global pharmaceutical support vehicle. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen supplies a broad range of medical commodities including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The Loestrin FE delivery represents a routine procurement of contraceptive medication to meet military and federal healthcare system needs, consistent with the company's extensive portfolio of pharmaceutical product deliveries to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.6k | 9/11/25 |